Uso de antidepressivos pela população da cidade de São Paulo

Abstract

The World Health Organization estimated depression as the third cause of disability in the ranking of all diseases, responsible for 4.3% loss of healthy life years (DALY). The depressive disorder impairs the ability to function, leading to deficiency in the production of more than 50% of patients. The treatment may be pharmacotherapy, psychotherapy, and in some cases eletroconvulsive therapy. This study examined the prevalence of the use of antidepression medications in the city of São Paulo, Brazil and is part of a large study Pos traumatic stress disorder on the São Paulo city: prevalence, commordity and associated factors. This is a one phase cross-sectional survey carried out in São Paulo, Brazil. A multistage probability to size sampling scheme was performed in order to select the participants (3000). The measurements included psychiatric diagnoses (CIDI 2.1), and psychoactive medications. The interviews were carried between June/2007 February/2008. The statistical analyses will be weight-adjusted in order to take account of the design effects. The frequency of use of psychoactive medications in individuals with depressive disorder 13%, 12,8% make use of antidepressant medication and 8% benzodiazepines, so with a large number of concurrent use of two medications. Among those who are using antidepressants, 63% use selective serotonin reuptake inhibitors, 34% use a tricyclic antidepressant and the other 3% make use of selective inhibitors of noradrenaline reuptake and various antidepressants. Was associated with the use of antidepressant medications females (2,7; IC 95% 1,5 ¿ 4,9), age over 30 years, being widowed or divorced or separate without living with the partner, with schooling above 13 years. It was concluded that there is a great way to go in our country in relation to mental health policies. Advances such as ensuring access to medicines and qualified professionals have already occurred, but show still insufficient.